Parham Eshtehardi MD Profile picture
Sep 26, 2020 11 tweets 24 min read Read on X
#Tweetorial on #ASNC2020 session

⚡Selecting Between Different Functional Tests⚡

☢ vs 🧲 vs ⏺ ❓

🔘 Strengths/Limits of Lesion Specific vs Myocardial Ischemia
🔘 Comparing Dx Accuracy of Tests
🔘 Ischemia Testing in #INOCA
🔘 How to Select Best Noninvasive Test

1/9
#ASNC2020 #cvNuc
2/9
Dr Di Carli

☢ Issues with proposed #FFR threshold 0.8
☢ Exercise MPI correlates well with FFR but not at 0.8
☢ Benefit of FFR-guided revasc dominantly occurs w/ thresholds <0.8
☢ Quantification of lesion-specific #ischemia insufficient for patient mgmt
#ASNC2020 #cvNuc
3/9
Dr Di Carli

Lesion-specific #ischemia measurements (FFR/#FFRCT)

☢ Strength
Validated against ETT/MPI
Strong outcome data
Guidelines supported

☢ Limit
Controversial threshold (0.80 vs MPI-validated 0.66)
⬆ microvasc resist causes FFR pseudonormalization
#ASNC2020 #cvNuc
4/9
Dr Di Carli

Myocardial-specific #ischemia measurements

☢ Strength
High prognostic value
Widely available

☢ Limit
Moderate accuracy w/o flow measurement
Affected by more factors than epicardial stenosis
#ASNC2020 #cvNuc
5/9
Dr Knaapen

⚡️ FFR-CT is best of both worlds:
plaque burden + stenosis severity

☢ FFR guided revasc reduces revasc & QoL but doesn’t significantly reduce MI/death
☢ Not every CT can be analyzed for FFR-CT
☢ PACIFIC: FFR-CT outperformed other modalities
#ASNC2020 #cvNuc
6/9
Dr Taqueti @VTaqMD

☢ Large portion of pts with angina have no evidence of obstructive #CAD on anatomical testing
☢ Traditional perfusion imaging does not identify pts with #CMD
#CMD (#CFR<2.0) present in ~50% of pts with angina
#ASNC2020 #cvNuc @InocaInternati1
7/9
Dr Taqueti @VTaqMD

#CFR is more prognostic in♀than ♂
☢ CFR is a better prognostic factor than traditional img abnormalities
#thinkPET is gold standard for eval of #CMD
#whyCMR can be complementary to PET specially in #MINOCA
#ASNC2020 #cvNuc
8/9
Dr Berman

How to select?
• Dx
• Guiding mgmt (survival benefit & Sx)

☢ Knowing plaque burden beyond lumen is important b/c quantitative plaque assessment predicts outcome

#CFR is important b/c FFR does not assess diffuse atherosclerosis, #CMD #INOCA
#ASNC2020 #cvNuc
9/9
Dr Berman

☢ In PACIFIC intention to Dx, PET was superior (17% could not have FFRCT)

☢ Dx of #INOCA needs presence of ischemia & absence of obst CAD

☢ If interested in knowing CAD, knowledge of coronary anatomy (stenosis, plaque burden/type) is critical

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Parham Eshtehardi MD

Parham Eshtehardi MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CardioOBDoc

Sep 21, 2021
Prevalence of Subclinical Coronary Atherosclerosis in General Population
@CircAHA

1/x
🇸🇪 25K randomly invited individuals w/o known CAD underwent CCTA
🇸🇪 51% women
🇸🇪 50 to 64 yrs
🇸🇪 #SCAPIS (the Swedish Cardiopulmonary Bioimage Study)

ahajournals.org/doi/10.1161/CI…
2/x
🇸🇪 42.1% any CCTA-detected atherosclerosis

🇸🇪 5.2% any significant stenosis (≥50%)

🇸🇪 1.9% LM, prox LAD or 3VCAD

🇸🇪 8.3% any non-calcified plaque

🇸🇪 plaques most common in prox LAD

🇸🇪 Participants with only non-Ca plaques were rare (2.4%)

ahajournals.org/doi/10.1161/CI…
3/x
🇸🇪 Prevalence of CCTA-detected atherosclerosis ⬆ w/ ⬆ #CAC scores

🇸🇪#CAC-positive participants:
- Most w/ low (11 - 100) or ultralow (1 - 10) scores
- median score 35 (IQR 8 - 126)

🇸🇪 participants w/ #CAC zero & interm 10-yr risk, 9.2% had CCTA-verified atherosclerosis
Read 7 tweets
May 16, 2021
9/19
#Tweetorial #CMD #ACC21

#CMD shares similar RFs w epicardial atherosclerosis (traditional ASCVD RFs) & is associated with several biomarkers of inflammation, oxidative stress & coagulation

🔗futuremedicine.com/doi/10.2217/fc…
🔗sciencedirect.com/science/articl…
🔗atherosclerosis-journal.com/article/S0021-…
10/19
#Tweetorial #CMD #ACC21

There is significant overlap between #CMD & epicardial disease

Large number of patients w/ #CMD also have epicardial atherosclerosis (obstructive or non-obstructive) & epicardial endothelial dysfunction

🔗onlinelibrary.wiley.com/doi/abs/10.100…
11/19
#Tweetorial #CMD #ACC21

In our IVUS study:
✅ Most patients with #CMD had significant plaque burden
✅ Patients with #CMD had higher plaque burden & more diffuse atherosclerosis as compared to patients w/o CMD

🔗jacc.org/doi/full/10.10…
Read 11 tweets
May 16, 2021
#CMD #Tweetorial

⚡ Coronary Microvascular Dysfunction ⚡

1/19

📌 What Is #CMD
📌 Why Is #CMD Important❓

Based on my #ACC21 #ACCImaging presentation
2/19
#Tweetorial #CMD #ACC21

Let’s start by talking about angina

✅ Angina w/o obstructive CAD is very prevalent 

🔗ahajournals.org/doi/full/10.11…
3/19
#Tweetorial #CMD #ACC21

✅ Angina ➡ poor prognosis
✅ Angina with no obstructive CAD = ⬆ risks of CV events compared to no angina, even after adjusting for traditional RFs & co-morbidities

🔗academic.oup.com/eurheartj/arti…
Read 9 tweets
May 6, 2021
Join us at #ACC21 to learn about #CMD

✅ What Is #CMD & Why Is It Important?
✅ Dx & Risk Stratification of #CMD: Stress Testing & Noninvasive Imaging
✅ Catheter-Based Techniques in Dx of #CMD
✅ Emerging Link Between #CMD & #HFpEF
✅ Phenotype-Based Mngmt of #CMD Image
#ACC21 #CMD session details 👇

📅 Sat, May 15
⏰ 2PM ImageImageImageImage
#ACC21 #ACCImaging #CMD session starting in 15 mins
Don’t miss this educational session Image
Read 8 tweets
Sep 8, 2020
☢ Selecting Between Different Functional Tests in 2020? ☢

This should be most interesting session of virtual #ASNC2020

I am excited to be virtual moderator w/ expert speakers Dan Berman, Keon Nieman, Paul Knaapen, @mdicarli, @VTaqMD

#cvImaging #cvNuc #CardioTwitter ImageImageImage
Are you ready for most exciting #ASNC2020 session?

⚡Selecting Between Different Functional Tests⚡

☢ vs 🧲 vs ⏺ ❓

Let’s hear from #cvImaging giants
Keon Nieman, Paul Knaapen, @mdicarli @VTaqMD @danielbermanmd

📆 Sat, Sept 26
⏰ 2:15 to 3:30PM
🗒 bit.ly/333dRNO ImageImageImageImage
☢ This super exciting session starts in 3 hours ☢

📺 Tune in #cvNuc peeps to learn who benefits from ischemia testing & how to select best non-invasive test

⏰ 2:15 to 3:30PM
#ASNC2020 Image
Read 9 tweets
Aug 31, 2020
Did you know?

#ASNC2020 @MyASNC Virtual is scheduled over several wks

☢ Bulk of sessions ➡ Friday & Saturday, Sept 25 & 26

☢ Cases with Aces sessions ➡ once a wk, Sept 9 to Oct 7

☢ 2 #SoMe sessions ➡ Sept 10 & 17 at 4:00pm

☢ Technologist sessions ➡ Oct 3 Image
Join us on Sept 10 & 17 for #ASNC2020 virtual #SoMe sessions

1⃣ #SoMe Session Sep 10 @ 4:00pm EDT
☢ Leveraging #SoMe for Patient Care
bit.ly/3hPrbKC

2⃣ #SoMe Session Sep 17 @ 4:00pm EDT
☢ Steering Your Tweetanic
bit.ly/2GqaDes Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(